Genentech BioOncology and Cancer Clinical Trials

Explore selected currently enrolling late-stage trials

MIRROS

View eligibility for a Phase III trial in patients with relapsed/refractory acute myeloid leukemia.

IPATunity130

Learn about a Phase III trial in patients with mTNBC or HR+, HER2– breast cancer.

POLARIX

Discover a Phase III trial in patients with diffuse large B-cell lymphoma.

IPATential150

Find information about a Phase III trial in patients with metastatic castrate-resistant prostate cancer.

mTNBC=metastatic triple negative breast cancer; HR=hormone receptor; HER2=human epidermal growth factor receptor 2.
*Developed in collaboration with Array BioPharma.
Developed in collaboration with Seattle Genetics.

Contact Genentech to find appropriate clinical trials for your patients

Call the Trial Information Support Line to find a Genentech clinical trial: 1-888-662-6728 (US only)
Or email: global-roche-genentech-trials@gene.com

You can also browse all Genentech and Roche actively recruiting clinical trials in the United States and around the world by visiting ClinicalTrials.gov.